Anktiva

Active Ingredient(s): Nogapendekin Alfa Inbakicept-pmln
FDA Approved: * April 22, 2024
Pharm Company: * ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Anktiva 400 ug/.4ml Intravesical Solution
NDC: 81481-803
Labeler:
Altor Bioscience, LLC, An Indirect Wholly-owned Subsidiary of Immunitybio, Inc.